AUTHOR=Lin Yingtao , Li Cijuan , Wang Chang , Chen Jian , Huang Yuanqing 

TITLE=Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

JOURNAL=Frontiers in Immunology

VOLUME=15

YEAR=2024

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1481584

DOI=10.3389/fimmu.2024.1481584

ISSN=1664-3224